Herbs (Global Traditional) · Ayurveda
Jivanti (Leptadenia reticulata) (Leptadenia reticulata)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Jivanti (Leptadenia reticulata) is an Ayurvedic herb containing bioactive compounds like flavonoids and saponins that exhibit antioxidant and antimicrobial properties. The plant demonstrates free radical scavenging activity through its phenolic compounds and shows antifungal effects against Candida species in laboratory studies.
Jivanti is derived from Leptadenia reticulata, a twining herb belonging to the Asclepiadaceae family native to India. The plant's roots are the primary medicinal part, though aerial parts (leaves and stems) are also used, typically extracted as powders, decoctions, and various solvent extracts (methanolic, ethanolic, aqueous) for therapeutic applications.
No peer-reviewed human clinical trials, randomized controlled trials (RCTs), or meta-analyses were found in the provided research. Available evidence is limited to in vitro studies demonstrating antioxidant and antimicrobial properties, and documentation of traditional Ayurvedic applications.
Traditional Ayurvedic dosages: Powder form 4-6 g daily; Decoction 40-60 ml. No standardized extract dosages or clinical trial-derived dosing regimens are available. Consult a healthcare provider before starting any new supplement.
Jivanti (Leptadenia reticulata) is a medicinal herb used primarily for its bioactive phytochemical constituents rather than as a macronutrient source. Detailed proximate composition data is limited, but the following is established from phytochemical analyses: Bioactive compounds include hentriacontanol, β-sitosterol, and stigmasterol (phytosterols present in leaf and stem fractions); luteolin and apigenin (flavonoids identified in methanolic extracts, contributing to antioxidant activity with IC₅₀ = 267.13 µg/mL in DPPH assays); reticulin and leptadine (alkaloids isolated from root and stem bark); α- and β-amyrin (triterpenoids found in wax fractions of leaves); and hentriacontane and octacosanol (long-chain aliphatic hydrocarbons). Phenolic content reported at approximately 18–24 mg gallic acid equivalents (GAE)/g dry extract in methanolic preparations. Flavonoid content approximately 12–16 mg quercetin equivalents (QE)/g dry extract. Chlorophyll and carotenoid pigments are present in leaf tissue (exact concentrations not formally quantified in available literature). Protein and fiber content of the whole plant material have not been formally reported in nutritional databases; as a woody climber, crude fiber is expected to be moderate, and protein content would be low relative to dietary plant foods. Mineral content has not been systematically quantified. Bioavailability of key phytochemicals such as β-sitosterol is generally low (2–5% absorption range, consistent with plant sterols broadly); extraction solvent significantly affects yield, with methanolic extracts outperforming aqueous extracts for phenolics and flavonoids. Data reflects laboratory phytochemical studies; no standardized nutritional panel from human dietary use is available.
Jivanti's antioxidant effects occur through phenolic compounds and flavonoids that donate electrons to neutralize free radicals, with demonstrated IC₅₀ values of 267.13 µg/mL in DPPH assays. The antifungal activity appears to result from bioactive compounds in the methanolic extract disrupting fungal cell membrane integrity and metabolic processes. Traditional lactogenic effects may involve phytoestrogens that modulate prolactin pathways, though specific mechanisms require further research.
Current evidence for Jivanti consists primarily of in vitro laboratory studies rather than human clinical trials. Antioxidant research shows moderate free radical scavenging activity with IC₅₀ values around 267 µg/mL in cell-free assays. Antifungal studies demonstrate activity against Candida albicans and other fungal species using methanolic extracts in petri dish experiments. No published human clinical trials have validated the traditional lactogenic effects or established safe and effective dosing protocols for supplementation.
Safety data for Jivanti supplementation is limited due to lack of human clinical studies. Traditional Ayurvedic use suggests general tolerability, but specific side effects, optimal dosages, and contraindications have not been scientifically established. Potential interactions with medications, particularly antifungals or hormone therapies, remain unknown. Pregnant and breastfeeding women should avoid use despite traditional lactogenic claims, as safety during these periods has not been clinically validated.
